{"denoms":[{"counts":[{"groupId":"BG000","value":"625"},{"groupId":"BG001","value":"625"},{"groupId":"BG002","value":"623"},{"groupId":"BG003","value":"1873"}],"units":"Participants"}],"groups":[{"description":"Control therapy:\n\nCycles 1-6 received paclitaxel, 175 mg/m2 plus carboplatin AUC 6 plus placebo (starting in cycle 2) every 3 weeks.\n\nCycles 7-22 received placebo every 3 weeks.","id":"BG000","title":"Arm I (Placebo, Paclitaxel, Carboplatin)"},{"description":"Bevacizumab-initiation therapy:\n\nCycles 1-6 received paclitaxel, 175 mg/m2 plus carboplatin AUC 6 plus bevacizumab, 15 mg/kg (starting in cycle 2) every 3 weeks.\n\nCycles 7-22 received placebo every 3 weeks.","id":"BG001","title":"Arm II (Placebo, Paclitaxel, Carboplatin, Bevacizumab)"},{"description":"Bevacizumab-throughout therapy:\n\nCycles 1-6 received paclitaxel, 175 mg/m2 plus carboplatin AUC 6 plus bevacizumab, 15 mg/kg (starting in cycle 2) every 3 weeks.\n\nCycles 7-22 received bevacizumab, 15 mg/kg every 3 weeks.","id":"BG002","title":"Arm III (Paclitaxel, Carboplatin, Bevacizumab)"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.9","value":"59.3"},{"groupId":"BG001","spread":"10.3","value":"60.1"},{"groupId":"BG002","spread":"10.6","value":"59.7"},{"groupId":"BG003","spread":"10.6","value":"59.7"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"625"},{"groupId":"BG001","value":"625"},{"groupId":"BG002","value":"623"},{"groupId":"BG003","value":"1873"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"526"},{"groupId":"BG001","value":"519"},{"groupId":"BG002","value":"521"},{"groupId":"BG003","value":"1566"}]}],"title":"Non-Hispanic white"},{"categories":[{"measurements":[{"groupId":"BG000","value":"41"},{"groupId":"BG001","value":"37"},{"groupId":"BG002","value":"39"},{"groupId":"BG003","value":"117"}]}],"title":"Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"27"},{"groupId":"BG003","value":"80"}]}],"title":"Non-Hispanic black"},{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"25"},{"groupId":"BG003","value":"74"}]}],"title":"Hispanic"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"11"},{"groupId":"BG003","value":"36"}]}],"title":"Other or unspecified"}],"paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"participant"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"596"},{"groupId":"BG001","value":"596"},{"groupId":"BG002","value":"599"},{"groupId":"BG003","value":"1791"}]}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"9"}]}],"title":"Canada"},{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"12"},{"groupId":"BG003","value":"45"}]}],"title":"Japan"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"28"}]}],"title":"Korea, Republic of"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"311"},{"groupId":"BG001","value":"315"},{"groupId":"BG002","value":"305"},{"groupId":"BG003","value":"931"}]}],"title":"0 - fully active"},{"categories":[{"measurements":[{"groupId":"BG000","value":"272"},{"groupId":"BG001","value":"270"},{"groupId":"BG002","value":"267"},{"groupId":"BG003","value":"809"}]}],"title":"1 - restricted strenuous activity, ambulatory"},{"categories":[{"measurements":[{"groupId":"BG000","value":"42"},{"groupId":"BG001","value":"40"},{"groupId":"BG002","value":"51"},{"groupId":"BG003","value":"133"}]}],"title":"2 - ambulatory, difficulty walking"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"3 - limited self-care, partly confined to bed"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"4 - completely disabled, no self-care"}],"description":"5-point, ordinal scale specifying patient's ability to perform activities from 0(fully active) to 4(completely disabled, no self-care).","paramType":"NUMBER","title":"Gynecologic Oncology Group (GOG) Performance Status","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"1-limited to ovaries"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"1A-1 ovary involved, no ascites"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"1B-both ovaries involved, no ascites"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"1C-disease with capsules ruptured or ascites"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"2-disease with pelvic extension"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"2A-disease with extension to uterus and or tubes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"2B-disease with extension to other pelvic tissues"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"2C-disease with capsules ruptured or ascites"},{"categories":[{"measurements":[{"groupId":"BG000","value":"218"},{"groupId":"BG001","value":"205"},{"groupId":"BG002","value":"216"},{"groupId":"BG003","value":"639"}]}],"title":"3-disease w/ macroscopic implants outside pelvis"},{"categories":[{"measurements":[{"groupId":"BG000","value":"254"},{"groupId":"BG001","value":"256"},{"groupId":"BG002","value":"242"},{"groupId":"BG003","value":"752"}]}],"title":"3-disease w/ implants > 1 cm outside pelvis"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"3A-disease w/ microscopic implants, negative nodes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"3B-disease w/ abdominal implants <2cm, neg nodes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}]}],"title":"3C-disease w/ abdominal implants >2cm, pos nodes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"153"},{"groupId":"BG001","value":"164"},{"groupId":"BG002","value":"165"},{"groupId":"BG003","value":"482"}]}],"title":"4-distant metastatis"}],"description":"Clinical staging for primary carcinoma of the ovary (1985) from Stage 1 (limited to ovaries) to Stage 4 (distant metastatis)","paramType":"NUMBER","title":"International Federation of Gynecologic and Obstetrics (FIGO) Stage","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"541"},{"groupId":"BG001","value":"519"},{"groupId":"BG002","value":"524"},{"groupId":"BG003","value":"1584"}]}],"title":"Serous adenocarcinoma"},{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"24"},{"groupId":"BG003","value":"59"}]}],"title":"Endometrioid"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"20"},{"groupId":"BG003","value":"55"}]}],"title":"Clear cell"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"8"},{"groupId":"BG003","value":"19"}]}],"title":"Mucinous"},{"categories":[{"measurements":[{"groupId":"BG000","value":"45"},{"groupId":"BG001","value":"64"},{"groupId":"BG002","value":"47"},{"groupId":"BG003","value":"156"}]}],"title":"Other or not specified"}],"description":"Histologic(cell) type was obtained from the central GOG Pathology Committee review updated in September 2010.","paramType":"NUMBER","title":"Histologic Type","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"445"},{"groupId":"BG001","value":"465"},{"groupId":"BG002","value":"460"},{"groupId":"BG003","value":"1370"}]}],"title":"3"},{"categories":[{"measurements":[{"groupId":"BG000","value":"102"},{"groupId":"BG001","value":"86"},{"groupId":"BG002","value":"97"},{"groupId":"BG003","value":"285"}]}],"title":"2"},{"categories":[{"measurements":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"18"},{"groupId":"BG003","value":"82"}]}],"title":"1"},{"categories":[{"measurements":[{"groupId":"BG000","value":"42"},{"groupId":"BG001","value":"46"},{"groupId":"BG002","value":"48"},{"groupId":"BG003","value":"136"}]}],"title":"Not graded"}],"description":"Tumor grade was obtained from the central GOG Pathology Committee review updated in September 2010. All clear-cell tumors were classified as grade 3.","paramType":"NUMBER","title":"Tumor Grade","unitOfMeasure":"participants"}]}